Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014;13(23):3628-35.
doi: 10.4161/15384101.2014.985507.

Geroconversion: irreversible step to cellular senescence

Affiliations
Review

Geroconversion: irreversible step to cellular senescence

Mikhail V Blagosklonny. Cell Cycle. 2014.

Abstract

Cellular senescence happens in 2 steps: cell cycle arrest followed, or sometimes preceded, by gerogenic conversion (geroconversion). Geroconvesrion is a form of growth, a futile growth during cell cycle arrest. It converts reversible arrest to irreversible senescence. Geroconversion is driven by growth-promoting, mitogen-/nutrient-sensing pathways such as mTOR. Geroconversion leads to hyper-secretory, hypertrophic and pro-inflammatory cellular phenotypes, hyperfunctions and malfunctions. On organismal level, geroconversion leads to age-related diseases and death. Rapamycin, a gerosuppressant, extends life span in diverse species from yeast to mammals. Stress-and oncogene-induced accelerated senescence, replicative senescence in vitro and life-long cellular aging in vivo all can be described by 2-step model.

Keywords: aging; cell cycle arrest; gerogenic conversion; mTOR; oncogenic trsnformation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proliferation versus arrest. (A) Proliferation: Growth factors (GF) activate MAPK and mTOR pathways, driving cell growth (in size) and cell cycle. Cellular growth is balanced by cell division. (B) Quiescence: In the absence of GF, cell growth and cycle are at rest. (C) Pro-senescent cycle arrest: When the cycle cycle is blocked by p21 or p16, the growth promoting pathway (MAPK/mTOR) causes growth in size (hypertrophy).
Figure 2.
Figure 2.
Senescence vs. quiescence.
Figure 3.
Figure 3.
The dual role of p53 in senescence. P53 causes Arrest that is followed by geroconversion (green arrow). Yet, at very high levels, p53 can inhibit mTOR, suppressing geroconversion (yellow arrow) and leading to quiescence.
Figure 4.
Figure 4.
Arrest-Geroconversion model. Schematic representation of types of senescence (Arrest- red stop sign. Geroconversion – green arrow). (A) Typical arrest-induced senescence. DNA damage-induced senescence. CDK (p21 and 16)–induced senescence. (B) In the presence of rapamycin: geroconversion is slowed down and extended. (C) Oncogene-induced senescence. Oncogenes such as Ras empower growth, cause arrest and then empower geroconversion. (D) Replicative senescence of human cells in culture. Telomere shortening during cell proliferation eventually causes Arrest. Then geroconversion ensures senescence. (E) Replicative senescence of rodent cells in culture. Ovestumulation of mTOR by mitogen/nutrient/oxygen rich medium causes cellular hypertrophy.

References

    1. Mathon NF, Lloyd AC. Cell senescence and cancer. Nature Rev Cancer 2001; 1:203-213; http://dx.doi.org/10.1038/35106045 - DOI - PubMed
    1. Dulic V, Beney GE, Frebourg G, Drullinger LF, Stein GH. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol Cell Biol 2000; 20:6741-6754; PMID:10958672; http://dx.doi.org/10.1128/MCB.20.18.6741-6754.2000 - DOI - PMC - PubMed
    1. Wang Y, Meng A, Zhou D. Inhibition of phosphatidylinostol 3-kinase uncouples H2O2-induced senescent phenotype and cell cycle arrest in normal human diploid fibroblasts. Exp Cell Res 2004; 298:188-196; PMID:15242773; http://dx.doi.org/10.1016/j.yexcr.2004.04.012 - DOI - PubMed
    1. Campisi J. Suppressing cancer: the importance of being senescent. Science 2005; 309:886-887; PMID:16081723; http://dx.doi.org/10.1126/science.1116801 - DOI - PubMed
    1. Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova A, et al. . Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011; 479:547-551; PMID:22080947; http://dx.doi.org/10.1038/nature10599 - DOI - PubMed

MeSH terms